2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Saturday, June 11, 2016

5:30pm-7:30pm: Long Term Follow Up of Kidney Donors with Asymptomatic Renal Stones.

D. Serur,¹ M. Charlton,² K. Juluru,³ G. Salama,³ E. LoCastro,³ G. Bretzlaff,² C. Hartono.¹

Poster Session A: Kidney Donor Outcomes • Halls C&D

5:30pm-7:30pm: Long Term Outcome of Kidney Transplant Recipients Treated with Everolimus: Final 5-Years Results from the Certic Observational Study.

L. Furian,¹ L. Di Maria,² G. Cappelli,³ M. Carmellini,⁴ G. Spagnoletti,⁵ G. Piredda,⁶ P. Todeschini,⁷ S. Chiaramonte,⁸ G. Tisone.⁹

Poster Session A: Long Term Outcomes in Kidney Transplantation • Halls C&D

5:30pm-7:30pm: Long Term Results on Pancreas Transplant Beyond the Standard Indications, at a Single Center.

D. Ramisch,¹ N. Aguirre,¹ F. Moss,² P. Farinelli,¹ R. Fortunato,² L. Gutierrez,² P. Barros Schelotto,¹ H. Fraguas,³ P. Raffaele,² G. Gondolesi.¹

Poster Session A: Clinical Pancreas Transplantation and All Islet Cell Transplantation Topics • Halls C&D

5:30pm-7:30pm: Long-Term Deterioration of Graft Function (DeKAF) Study: Histologic Interpretation of Cross-sectional vs Prospective Cohorts.

A. Matas,¹ A. Fieberg,¹ L. Hunsicker,² J. Grande,³ For the DeKAF Group.

Poster Session A: Long Term Outcomes in Kidney Transplantation • Halls C&D

5:30pm-7:30pm: Long-Term Follow-Up of Renal Transplant Recipients (RTR) Treated with IVIG for De Novo Donor Specific Antibodies (DSA).

R. Knight,¹ S. Patel,¹ J. Loucks-DeVos,² S. Kuten,¹ A. Gaber.¹

Poster Session A: Long Term Outcomes in Kidney Transplantation • Halls C&D

5:30pm-7:30pm: Long-Term Outcomes After Splenectomy for Small-for-Size Syndrome in Live Donor Liver Transplantation.

M. Dib, N. Goldaracena, A. Barbas, M. Marquez, G. Sapisochin, C. Beriault, N. Selzner, I. McGilvray, E. Renner, P. Greig, L. Lilly, A. Ghanekar, M. Cattral, M. Selzner, D. Grant.

Poster Session A: Living Donor Liver Transplantation • Halls C&D

5:30pm-7:30pm: Longitudinal Psychological Outcomes of Living Liver Donors.

Z. Butt,¹ M. Dew,² Q. Liu,³ M. Simpson,⁴ A. Smith,^3,5 J. Zee,³ B. Gillespie,⁵ S. Abbey,⁶ D. Ladner,¹ R. Weinreib,⁷ R. Fisher,⁸ S. Hafliger,⁹ N. Terrault,¹⁰ J. Burton,¹¹ A. DiMartini.²

Poster Session A: Living Donor Liver Transplantation • Halls C&D

5:30pm-7:30pm: Low Risk of Cytomegalovirus (CMV) Transmission in Clinical Islet Transplantation.

D. Kabbani,¹ K. Cheung,² P. Senior,² C. Cervera,¹ K. Doucette,¹ J. Preiksaitis.¹

Poster Session A: Clinical Pancreas Transplantation and All Islet Cell Transplantation Topics • Halls C&D

5:30pm-7:30pm: Measuring Efficacy of Antibody Removal Therapies: Back to Titers.

A. Tambur,¹ D. Glotz,² N. Herrera,¹ E. Chatroop,¹ T. Roitberg,¹ J. Friedewald,¹ D. Gjertson.³

Poster Session A: Kidney Desensitization • Halls C&D

5:30pm-7:30pm: Mechanical Thrombectomy for the Treatment of Pancreas Transplant Venous Thrombosis: A Single Center Experience.

S. Shin,¹ H. Ko,² K. Ko,² Y. Kim,¹ J. Choi,¹ J. Jung,¹ D. Han.¹

Poster Session A: Clinical Pancreas Transplantation and All Islet Cell Transplantation Topics • Halls C&D